Extracellular matrix and cell-surface adhesion machinery (ECM/CAM)

The extracellular matrix (ECM) and cell-surface adhesion machinery represent a complex, multi-component network of extracellular macromolecules, such as collagen, enzymes, and glycoproteins, that provide structural and biochemical support to surrounding cells (Source: NIH/NCBI). This specific entry is classified as "non-specific" because it refers to a broad functional grouping of proteins and structures rather than a single molecular target or receptor. The machinery is essential for maintaining tissue integrity, facilitating cell-to-cell communication, and regulating physiological processes like angiogenesis and immune cell trafficking (Source: Nature Reviews Molecular Cell Biology). In pathological states, such as cancer, the ECM is often remodeled to facilitate tumor cell invasion and metastasis, while in fibrotic disorders, excessive deposition of matrix components leads to organ scarring (Source: Journal of Cell Biology). Therapeutic interventions in this category often involve enzymes like collagenase or hyaluronidase that degrade specific matrix elements, or protective agents like sucralfate that bind non-specifically to exposed tissue proteins to form a physical barrier (Source: PubChem). Because this target encompasses a wide array of proteins, pharmacological modulation often carries risks of affecting healthy tissue architecture alongside the intended therapeutic site.

Other names

Extracellular matrixCell adhesion moleculesIntercellular matrixAdhesion machineryECM components

Drugs targeting this machinery typically act through enzymatic degradation of matrix components, non-specific physical binding to exposed proteins, or competitive inhibition of broad adhesion motifs.